Figure 1.
PCDAI scores and trabecular BMD and corical area z scores following initiation of infliximab therapy. Greater declines in PCDAI scores over the first 10 weeks were significantly associated with greater gains in trabecular BMD and cortical area z scores over the 12-month study. The dashed lines represent the median z scores in the reference participants.
